Olanzapine-induced agranulocytosis: A case report and review of the literature

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 26, Issue 2, 2002, Pages 411-414

  Tolosa Vilella, Carles ^a   Ruiz Ripoll, Ada ^b   Mari Alfonso, Begoa ^a   Naval Sendra, Elsa ^a  

^a Consorci Sanitari Parc Taulí Sabadell ^*  (Spain)

^b Psychiatry Section   (Spain)

Author keywords

Olanzapine induced agranulocytosis

Indexed keywords

AMIKACIN; CYANAMIDE; OLANZAPINE; PIPERACILLIN;

ADULT; AGRANULOCYTOSIS; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTROLLED STUDY; DELUSION; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; HUMAN; LEUKOCYTE COUNT; MALE;

AGRANULOCYTOSIS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; HUMANS; MALE; MIDDLE AGED; PIRENZEPINE;

EID: 0036137890     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(01)00258-5     Document Type: Article

References (23)

1. Clozapine-induced agranulocytosis. Incidence and risk factors in the United States
2. Safety of olanzapine
3. Olanzapine-induced neutropenia after clozapine-induced neutropenia
4. The relationship of pharmacology to side effects
5. Genetic determinants of drug-induced agranulocytosis: Potential risk of olanzapine?
6. Olanzapine treatment in patients with typical and atypical neuroleptic-associated agranulocytosis
7. Prolongation of clozapine-induced granulocytopenia associated with olanzapine
8. Olanzapine-induced neutropenia
9. A comparison of the oxidation of clozapine and olanzapine to reactive metabolites and the toxicity of these metabolites to human leukocytes
10. A comparison of the covalent binding of clozapine and olanzapine to human neutrophils in vitro and in vivo
11. Drugs that induce neutropenia/agranulocytosis may target specific components of the stromal cell extracellular matrix
12. Clozapine is oxidized by activated human neutrophils to a reactive nitrenium ion that irreversibly binds to the cells
13. Reversible leukopenia related to olanzapine
14. Olanzapine-induced agranulocytosis
15. Olanzapine: Safe during clozapine-induced agranulocytosis
16. Granulocyte colony-stimulating factor plasma levels during clozapine- and olanzapine-induced granulocytopenia
17. Treatment of severe clozapine-induced neutropenia with granulocyte colony-stimulating factor (G-CSF). Remission despite continuous treatment with clozapine
18. Two cases of olanzapine-induced reversible neutropenia
19. Olanzapine treatment after clozapine-induced granulocytopenia in 3 patients
20. Evidence that lithium induces human granulocyte proliferation: Elevated serum B 12 binding capacity in vivo and granulocyte colony proliferation in vitro
21. Olanzapine-induced agranulocytosis
22. Oxidation of aminopyrine by hypochlorite to a reactive dication: Possible implications for aminopyrine-induced agranulocytosis
23. Oxidation of propilthiouracil to reactive metabolites by activated neutrofils: Implications for agranulocytosis